Transgene
Transgene is a biopharmaceutical company specializing in the design and development of immunotherapeutic products for treating cancers and chronic infectious diseases. The company offers expertise across all stages of product development, including research, clinical trials, and manufacturing.
Top Stages
1 past transactions
ElsaLys Biotech
Series A in 2013
ElsaLys Biotech is a clinical-stage biotechnology company based in Lyon and Strasbourg, France, that specializes in the design and development of therapeutic antibodies aimed at treating tumors and their associated immune and vascular microenvironments. Founded in 2013, ElsaLys Biotech is focused on advancing its research and development programs, which include multiple oncology initiatives and ophthalmology projects. The company's innovative approach seeks to harness the potential of monoclonal antibodies to improve therapeutic outcomes for patients facing various cancers and eye diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.